Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Melanoma of the Skin (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Recentaapc
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 22.5 (22.4, 22.5) N/A 83,836 stable stable trend 1.5 (-0.9, 2.7)
Massachusetts 7 20.0 (19.6, 20.5) 40 (37, 41) 1,686 falling falling trend -7.2 (-12.0, -4.2)
Pennsylvania 6 21.3 (21.0, 21.6) 34 (31, 37) 3,484 falling falling trend -3.8 (-6.4, -1.9)
South Carolina 6 22.6 (22.0, 23.1) 27 (25, 32) 1,428 falling falling trend -3.6 (-6.4, -0.4)
Oklahoma 6 21.3 (20.7, 21.9) 33 (30, 37) 956 falling falling trend -3.4 (-7.8, -0.6)
Oregon 6 24.2 (23.6, 24.8) 22 (19, 26) 1,242 falling falling trend -3.3 (-8.0, -0.1)
Rhode Island 6 21.3 (20.2, 22.5) 32 (26, 40) 285 falling falling trend -3.0 (-7.4, -0.2)
Connecticut 7 18.8 (18.2, 19.4) 42 (41, 43) 865 falling falling trend -2.0 (-3.0, -1.2)
Georgia 7 25.1 (24.7, 25.5) 19 (15, 22) 2,869 stable stable trend -2.0 (-5.4, 1.3)
Wisconsin 6 23.8 (23.3, 24.3) 25 (20, 26) 1,673 stable stable trend -1.4 (-4.5, 0.8)
Delaware 6 27.1 (25.8, 28.5) 13 (7, 18) 346 stable stable trend -1.2 (-4.6, 0.6)
New Mexico 7 16.7 (16.0, 17.5) 46 (44, 46) 437 stable stable trend -0.7 (-3.5, 0.2)
Colorado 6 21.2 (20.7, 21.8) 35 (30, 37) 1,322 stable stable trend -0.2 (-2.9, 0.7)
Florida 6 25.4 (25.1, 25.6) 17 (14, 20) 7,538 stable stable trend -0.2 (-3.7, 3.0)
Tennessee 6 20.1 (19.6, 20.5) 39 (37, 40) 1,620 stable stable trend -0.1 (-1.7, 1.1)
North Dakota 6 23.9 (22.4, 25.5) 23 (15, 32) 194 stable stable trend 0.1 (-2.9, 1.9)
Washington 5 25.5 (25.0, 26.0) 16 (14, 21) 2,201 stable stable trend 0.2 (-1.0, 0.6)
Alabama 6 21.9 (21.3, 22.4) 31 (27, 36) 1,281 stable stable trend 0.4 (-2.4, 1.8)
New Jersey 7 21.0 (20.6, 21.4) 36 (32, 38) 2,295 stable stable trend 0.4 (0.0, 0.7)
Missouri 6 18.7 (18.2, 19.1) 43 (41, 43) 1,351 stable stable trend 0.6 (-0.2, 1.2)
New Hampshire 6 30.5 (29.3, 31.7) 4 (4, 8) 550 stable stable trend 0.6 (-0.6, 1.9)
New York 7 17.7 (17.5, 18.0) 44 (44, 46) 4,216 stable stable trend 0.6 (-0.2, 1.3)
West Virginia 6 22.3 (21.5, 23.3) 30 (24, 36) 530 stable stable trend 0.7 (-3.5, 2.0)
Michigan 6 20.1 (19.8, 20.5) 38 (37, 40) 2,438 rising rising trend 0.8 (0.2, 1.4)
District of Columbia 6 9.3 (8.3, 10.4) 49 (49, 49) 65 stable stable trend 1.1 (-0.4, 2.8)
Mississippi 6 18.8 (18.2, 19.5) 41 (40, 44) 642 stable stable trend 1.1 (-2.0, 2.1)
Utah 7 40.8 (39.7, 41.9) 1 (1, 1) 1,147 stable stable trend 1.1 (-1.2, 3.1)
California 7 22.4 (22.2, 22.6) 29 (26, 31) 9,811 rising rising trend 1.3 (1.0, 1.6)
North Carolina 6 25.7 (25.3, 26.1) 15 (13, 20) 3,157 stable stable trend 1.3 (-0.7, 2.3)
Maine 6 26.9 (25.8, 28.1) 14 (8, 18) 500 rising rising trend 1.5 (0.8, 2.2)
Alaska 6 14.2 (12.9, 15.5) 47 (47, 48) 104 rising rising trend 1.8 (0.3, 3.5)
Vermont 6 36.6 (34.7, 38.6) 2 (2, 3) 301 rising rising trend 1.8 (0.4, 3.3)
Idaho 7 30.0 (28.9, 31.1) 6 (4, 9) 588 rising rising trend 1.9 (1.3, 2.6)
Wyoming 6 23.8 (22.2, 25.6) 24 (14, 33) 165 rising rising trend 1.9 (0.2, 3.8)
Kentucky 7 27.7 (27.0, 28.4) 10 (8, 14) 1,447 rising rising trend 2.0 (1.7, 2.5)
Hawaii 7 24.4 (23.4, 25.5) 21 (15, 26) 443 stable stable trend 2.2 (-4.4, 4.0)
Montana 6 28.2 (26.8, 29.6) 9 (5, 14) 373 stable stable trend 2.2 (-0.5, 3.5)
Virginia 6 20.9 (20.5, 21.3) 37 (32, 38) 2,075 rising rising trend 2.4 (0.7, 6.9)
Kansas 6 27.2 (26.4, 28.1) 12 (8, 14) 896 rising rising trend 2.6 (2.0, 3.2)
Ohio 6 25.3 (24.9, 25.7) 18 (15, 21) 3,571 rising rising trend 2.6 (2.0, 3.3)
Maryland 6 24.5 (24.0, 25.1) 20 (17, 25) 1,745 rising rising trend 2.9 (1.5, 5.9)
Louisiana 7 17.5 (17.0, 18.0) 45 (43, 46) 920 rising rising trend 3.2 (2.5, 4.0)
Iowa 7 30.1 (29.3, 31.0) 5 (4, 7) 1,108 rising rising trend 3.4 (3.1, 3.7)
Nebraska 6 28.3 (27.2, 29.3) 8 (6, 14) 598 rising rising trend 3.6 (0.7, 6.7)
South Dakota 6 27.3 (25.8, 28.8) 11 (6, 19) 277 rising rising trend 4.1 (3.1, 5.5)
Texas 7 14.1 (14.0, 14.3) 48 (47, 48) 4,067 rising rising trend 4.5 (1.0, 7.2)
Illinois 7 22.5 (22.2, 22.9) 28 (25, 31) 3,317 rising rising trend 4.8 (3.7, 6.6)
Puerto Rico 6 3.5 (3.2, 3.7) N/A 135 stable stable trend 4.9 (-7.8, 19.4)
Arkansas 6 23.6 (22.9, 24.4) 26 (20, 28) 846 rising rising trend 5.1 (4.5, 5.9)
Minnesota 6 36.0 (35.4, 36.7) 3 (2, 3) 2,319 rising rising trend 6.0 (4.9, 7.5)
Arizona 6 28.9 (28.4, 29.4) 7 (5, 10) 2,552 rising rising trend 6.5 (5.0, 10.9)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 03/04/2024 2:25 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top